Dual role of GRK5 in cancer development and progression

J Gambardella1, A Franco2, C Del Giudice2

  • 1Department of Medicine and Surgery -University of Salerno, Italy;

Insights

G protein-coupled receptor kinase 5 (GRK5) plays a dual role in cancer, potentially inhibiting or promoting tumor growth. Targeting GRK5 offers a promising anti-cancer strategy for specific tumor types.

Area of Science:

  • Molecular Biology
  • Cellular Signaling
  • Oncology

Background:

  • GRK5 is a multifunctional protein involved in intracellular signaling pathways.
  • GRK5's subcellular localization influences its role in various cellular processes.
  • GRK5 has been implicated in the development and progression of cancer.

Purpose of the Study:

  • To review the diverse roles of GRK5 in tumorigenesis.
  • To elucidate the molecular mechanisms underlying GRK5's pro- and anti-tumorigenic effects.
  • To explore therapeutic strategies targeting GRK5 in cancer treatment.

Main Methods:

  • Review of existing scientific literature on GRK5 and cancer.
  • Analysis of studies detailing GRK5's interactions with receptors and non-receptor substrates.
  • Examination of evidence linking GRK5's subcellular localization to its function.

Main Results:

  • GRK5 exhibits context-dependent effects on tumor growth, acting as both an inhibitor and promoter.
  • Inhibition of cancer progression is mediated by desensitization of G protein-coupled receptors (GPCRs) and non-GPCRs.
  • Tumor growth induction involves GRK5's action on non-receptor substrates like p53, AUKA, and NPM1.

Conclusions:

  • GRK5's dual role in cancer necessitates a nuanced understanding of its function.
  • Targeting GRK5 presents a potential therapeutic avenue for specific cancer types.
  • Further research is needed to fully exploit GRK5 as an anti-cancer target.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.5K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.6K